Capstone Change Project Implementation Plan
Literature Evaluation Table
Student Name: Sashane Ellis
Faculty Name: Professor Leslie Greenberg
Finalized PICOT Question: In adult patients with diabetes, how does implementation of telehealth support, compared to standard in-person care, affect compliance with diabetes management protocols within six months?
Literature Search Strategy Employed (in 100 words or less describe the library databases that you searched and the keywords that you used to find research articles) :
I searched academic databases including PubMed, CINAHL, and ProQuest Nursing & Allied Health. Keywords and Boolean operators used were: "diabetes AND telehealth," "telemedicine AND diabetes management," "diabetes compliance AND telehealth support," "standard in-person care AND diabetes outcomes," and "diabetes management protocols AND technology." Filters were applied to include peer-reviewed articles published within the last five years, focusing on adult populations. I also used MeSH terms such as "Diabetes Mellitus," "Telemedicine," and "Patient Compliance" to refine results and ensure alignment with the PICOT question
|
Criteria |
Article 5 |
Article 6 |
Article 7 |
Article 8 |
|
APA Reference (include the GCU permalink or working link used to access the article) |
Rodriguez, H. P., Ciemins, E., Rubio, K., Rattelman, C., Cuddeback, J. K., Mohl, J. T., Bibi, S., & Shortell, S. M. (2024). Telemedicine use and decrements to type 2 diabetes and hypertension care during the COVID-19 pandemic. BMC Digital Health, 2(1). https://doi.org/10.1186/s44247-023-00056-7 |
Sotomayor, F., Hernández, R. C., Malek, R., Parimi, N., & Spanakis, E. K. (2023). The Effect of Telemedicine in Glycemic Control in Adult Patients with Diabetes during the COVID-19 Era—A Systematic Review. Journal of Clinical Medicine, 12(17), 5673–5673. https://doi.org/10.3390/jcm12175673 |
Dhediya, R., Chadha, M., Bhattacharya, A. D., Godbole, S., & Godbole, S. (2022). Role of telemedicine in diabetes management. Journal of Diabetes Science and Technology, 17(3), 193229682210811. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210114/
|
AlQassab, O., Kanthajan, T., Pandey, M., Francis, A. J., Sreenivasan, C., Parikh, A., & Nwosu, M. (2024). Evaluating the Impact of Telemedicine on Diabetes Management in Rural Communities: A Systematic Review. Cureus, 16(7). https://doi.org/10.7759/cureus.64928
|
|
Purpose/Aim of Study |
To examine the effects of telemedicine use on the quality of diabetes and hypertension care during the COVID-19 pandemic. |
The study evaluates telemedicine's effectiveness in managing diabetes during the COVID-19 pandemic, focusing on its impact on glycemic control measures like HbA1c and time-in-range (TIR). |
The study aims to explore telemedicine’s role in diabetes management by evaluating its feasibility, effectiveness, and potential integration into routine care. |
The study aims to evaluate the impact of telemedicine on glycemic control in diabetic patients in rural settings, identifying benefits, challenges, and potential improvements in diabetes management. |
|
Research questions (Qualitative)/Hypothesis (Quantitative) |
Hypothesis : Telemedicine use was more strongly associated with blood pressure testing and control for adults with type II diabetes compared to those with hypertension-only |
Hypothesis : telemedicine improves glycemic control measures (e.g., HbA1c, TIR, GMI) compared to standard in-person care |
Hypothesis: Telemedicine improves glycemic control and self-management compared to traditional in-person care. |
Hypothesis: Telemedicine improves glycemic control (HbA1c) in rural diabetic patients compared to standard care. |
|
Design Type of quantitative or type of qualitative study design |
A quantitative, retrospective cohort study using pre- and post-pandemic data |
Quantitative, retrospective observational analysis with some prospective data components. |
Quantitative meta-analysis and randomized controlled trials (RCTs). |
Systematic review of recent studies on telemedicine in rural diabetes care. |
|
Setting Where did the study take place? What type of setting – inpatient, outpatient, etc.? |
Outpatient settings across ten U.S. health systems. |
Outpatient settings during the COVID-19 pandemic. |
Outpatient care, including primary health care settings. |
Studies were conducted in rural outpatient settings across various regions. |
|
Sample Number and characteristics of participants |
1,963,563 adult patients diagnosed with type 2 diabetes and/or hypertension. |
317 studies focused on non-pregnant adults with type 1 or type 2 diabetes. |
Diverse studies covering over 20,000 participants, including adults with Type 1, Type 2, and gestational diabetes. |
The review included 10 studies with participants aged 18+ from rural areas, totaling 20,000+ individuals. |
|
Methods Interventions/Instruments |
Telemedicine encounters were analyzed for HbA1c and BP testing and control using electronic health records. |
Use of telecommunication (e.g., video conferencing) with glucose monitoring tools (CGM, SMBG, FGM). |
Telehealth interventions included telemonitoring, tele-education, and teleconsultation, evaluated for HbA1c levels and patient satisfaction. |
The review assessed telemedicine interventions like remote monitoring and digital health tools. |
|
Analysis How were the data that were collected analyzed? |
Generalized linear models and inverse propensity treatment weighting were applied to compare outcomes. |
Data analyzed through glycemic measures (e.g., HbA1c, TIR), emphasizing statistical comparisons between telemedicine and in-person care. |
Statistical analysis using meta-analyses, odds ratios, and cost-effectiveness evaluations. |
Data were analyzed using PRISMA guidelines and quality appraisal tools, including meta-analysis and risk assessment frameworks. |
|
Outcomes/key findings of the study and implications for nursing practice (Summary of study results) |
Telemedicine reduced HbA1c and BP testing but did not significantly affect control rates. Implications highlight the need for hybrid care models. |
Telemedicine showed improved glycemic control, highlighting its potential for diabetes care and implications for accessible management. |
Telemedicine reduced HbA1c, improved diabetes self-management, and enhanced cost-effectiveness, though challenges remain for marginalized populations. |
Telemedicine significantly improved HbA1c, medication adherence, and timely care while being cost-effective. It showed reduced effectiveness for patients with comorbidities. |
|
Recommendations of the Researcher |
Integrate remote monitoring tools and partnerships to complement telemedicine. |
Further research is needed via randomized clinical trials to solidify telemedicine’s role post-pandemic. |
The study recommends increase in telehealth accessibility and tailoring strategies for diverse populations. |
Hybrid models combining telemedicine and in-person care, better infrastructure, and further randomized controlled trials were recommended. |
|
Explain how this article supports your proposed PICO(T) question and Capstone Change Project |
Supports the PICOT focus on telehealth by highlighting its limitations and potential in diabetes care, aligning with the capstone project’s aim to improve compliance. |
The article supports the PICOT question by demonstrating telemedicine's effectiveness in improving diabetes compliance, aligning with the Capstone Change Project's goals. |
The article validates telehealth as a viable method to enhance diabetes management compliance, directly addressing the PICOT question and advancing telehealth integration in nursing practice. |
The article supports the PICOT question by demonstrating telemedicine’s efficacy in improving compliance with diabetes management protocols. Its findings align with the Capstone project, emphasizing innovative, accessible care approaches. |
References
AlQassab, O., Kanthajan, T., Pandey, M., Francis, A. J., Sreenivasan, C., Parikh, A., & Nwosu, M. (2024). Evaluating the Impact of Telemedicine on Diabetes Management in Rural Communities: A Systematic Review. Cureus, 16(7). https://doi.org/10.7759/cureus.64928
Ballesta, S., Chillarón, J., Inglada, Y., Climent, E., Llauradó, G., Pedro‐Botet, J., Cots, F., Camell, H., Flores, J. A., & Benaiges, D. (2023). Telehealth model versus in-person standard care for persons with type 1 diabetes treated with multiple daily injections: an open-label randomized controlled trial. Frontiers in Endocrinology, 14. https://doi.org/10.3389/fendo.2023.1176765
Chiaranai, C., Chularee, S., Saokaew, S., Bhatarasakoon, P., Umnuaypornlert, A., Chaomuang, N., Doommai, N., & Nimkuntod, P. (2024). Effectiveness of telehealth on the glycemic control of patients with type 2 diabetes mellitus during the COVID-19 pandemic: A systematic review and meta-analysis of randomised controlled trials. International Journal of Nursing Studies Advances, 6, 100169. https://doi.org/10.1016/j.ijnsa.2023.100169
Dat, T. V., Binh, V., Hoang, T. M., Tu, V. L., Luyen, P. D., & Thi, L. (2024). The effectiveness of telemedicine in the management of type 2 diabetes: A systematic review. SAGE Open Medicine, 12. https://doi.org/10.1177/20503121241271846
Dhediya, R., Chadha, M., Bhattacharya, A. D., Godbole, S., & Godbole, S. (2022). Role of telemedicine in diabetes management. Journal of Diabetes Science and Technology, 17(3), 193229682210811. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210114/
Rodriguez, H. P., Ciemins, E., Rubio, K., Rattelman, C., Cuddeback, J. K., Mohl, J. T., Bibi, S., & Shortell, S. M. (2024). Telemedicine use and decrements to type 2 diabetes and hypertension care during the COVID-19 pandemic. BMC Digital Health, 2(1). https://doi.org/10.1186/s44247-023-00056-7
Shao, Y., Shi, L., Nauman, E., Price‐Haywood, E. G., & Stoecker, C. (2023). Telehealth use and its impact on clinical outcomes in patients with type 2 diabetes during the COVID‐19 pandemic. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15293
Sotomayor, F., Hernández, R. C., Malek, R., Parimi, N., & Spanakis, E. K. (2023). The Effect of Telemedicine in Glycemic Control in Adult Patients with Diabetes during the COVID-19 Era—A Systematic Review. Journal of Clinical Medicine, 12(17), 5673–5673. https://doi.org/10.3390/jcm12175673
© 2023. Grand Canyon University. All Rights Reserved.
2